Gossamer Bio (NASDAQ:GOSS) Bolsa, Quote.MetaTitle.unusual-options

Gossamer Bio

Gossamer Bio Inc

GOSSAN RESOURCES LTD CDA by Gossan Resources Ltd.

Gossan Resources Ltd

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Astria Therapeutics

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

CytomX Therapeutics

Emergent BioSolutions

Erasca

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Inventiva S.A. - American Depository Shares

Inventiva

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharmaceuticals

Keros Therapeutics

Lexeo Therapeutics

MeiraGTx Hldgs

MapLight Therapeutics, Inc. - Common Stock

MapLight Therapeutics

Myriad Genetics

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Prime Medicine

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Replimune Group

Regenxbio

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

Vir Biotechnology

Verastem

Gossamer Bio (GOSS) Previsión

Noticias

Beneficios

Opciones

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Comments

Gossamer Bio Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL